Engineering Injectable Microporous Hydrogels for Diabetic Wound Repair
Engineering Injectable Microporous Hydrogels for Diabetic Wound Repair
批准号:
10657614
负责人:
Donald Richieri Griffin
金额:
$63.04万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-08-02 至 2026-06-30
关键词:
AccelerationAddressAffinityAmino Acid SubstitutionAnimal ModelBehaviorBiocompatible MaterialsBlood VesselsBrainCell LineCellsChemicalsClinicalComplicationCrosslinkerDefectDermalDiabetic Foot UlcerDiabetic mouseDiameterEngineeringEnvironmentEnzymesExhibitsFamily suidaeForeign-Body ReactionFormulationGelGenerationsGeometryGoalsHair follicle structureHeparinHeterogeneityHistologyHydrogelsImmune responseImmunofluorescence ImmunologicIn SituIn VitroIndividualInflammationInflammatoryInjectableInstructionIntestinesIntramuscularInvestigationIslandLower ExtremityMacrophageMechanicsMediatingMicrofluidicsMicroscopicMicrospheresNatural regenerationOutcomePathologicPatientsPeptidesPerfusionPilot ProjectsPorosityPredispositionProliferatingPropertyProteolysisResistanceSkinSkin wound healingSplint DeviceStructureTestingThickTissuesUlcerVascularizationWound modelsangiogenesisarticular cartilagebioscaffoldcell behaviorcell motilitychemokinedesigndiabeticdiabetic ulcerdiabetic wound healinghealingimmune activationimmunogenicityimmunoregulationimplantationimprovedin vivoinventionlimb amputationmigrationnon-diabeticnovelparticleporous hydrogelpost strokeprematureratiometricregenerativeresponsescaffoldsecondary outcomestandard of caretissue regenerationwoundwound closurewound environmentwound healingwound treatment
中文摘要
项目总结
英文摘要
PROJECT SUMMARY
In this proposal, we aim to engineer a biomaterial scaffold to accelerate diabetic wound closure by improving upon a
new sub-class of hydrogel biomaterials we have invented called Microporous Annealed Particle gel or MAP gel. MAP
gels are composed of microscopic spherical building blocks made using microfluidic generation and assembled in situ to
form a stable MAP scaffold. MAP scaffolds have been shown to improve tissue healing in both skin and brain through a
porosity-dependent reduction in wound inflammation and promotion of cell/tissue integration. We are focusing on
material improvements to counter three known difficulties for material-based treatment of diabetic wounds: abnormally
high immune activation, increased degradative microenvironment, and diminished new tissue generation. Specifically, we
have identified three MAP properties that we can independently modulate for scientific optimization: pore geometry
(known immunomodulatory parameter), degradability (premature material degradation results in loss of porous
geometry), and heterogeneous heparin “micro-islands” (a novel material strategy we have developed to improve intra-
scaffold angiogenesis). We hypothesize that investigating and optimizing each property individually will accelerate
diabetic wound closure and, finally, that the optimized properties can be combined synergistically.
We will evaluate and optimize each material property using the following characterization workflow: in vitro property
quantification (property-dependent), in vitro cell response (survival, proliferation, and migration), in vivo immune
response (analysis by FACS), in vivo material degradation (analysis by histology), and in vivo tissue healing/regeneration
(analysis by immunohistology). Our studies focus on the diabetic wound environment through use of dermal cell lines in
vitro and a diabetic mouse (db/db) splinted wound healing model. Each Aim of our approach isolates an individual
material property to simplify the investigation. For example, pore geometry impact is investigated using a single hydrogel
formulation and hydrogel formulation impact uses a single pore geometry (constant formulation and pore geometry taken
from our successful non-diabetic studies). If successful, this project will provide a better understanding of tissue response
to a new class of biomaterial and produce an inexpensive and effective scaffold treatment option for accelerating diabetic
wound closure.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1038/s41536-023-00281-8
发表时间:
2023-02-23
期刊:
NPJ REGENERATIVE MEDICINE
影响因子:
7.2
作者:
[Pruett, Lauren J., Kenny, Hannah L., Swift, William M., Catallo, Katarina J., Apsel, Zoe R., Salopek, Lisa S., Scumpia, Philip O., Cottler, Patrick S., Griffin, Donald R., Daniero, James J.]
通讯作者:
Daniero, James J.
DOI:
10.1016/j.actbio.2022.05.049
发表时间:
2022-08
期刊:
ACTA BIOMATERIALIA
影响因子:
9.7
作者:
[Pruett, Lauren J., Taing, Alex L., Singh, Neharika S., Peirce, Shayn M., Griffin, Donald R.]
通讯作者:
Griffin, Donald R.
Engineering Injectable Microporous Hydrogels for Diabetic Wound Repair
-
批准号:10460610
-
项目类别:
-
资助金额:$64.44万
-
财政年份:2021
-
负责人:Donald Richieri Griffin
-
依托单位:
Engineering Injectable Microporous Hydrogels for Diabetic Wound Repair
-
批准号:10297936
-
项目类别:
-
资助金额:$64.44万
-
财政年份:2021
-
负责人:Donald Richieri Griffin
-
依托单位:
Engineering Injectable Microporous Hydrogels for Diabetic Wound Repair
-
批准号:10161123
-
项目类别:
-
资助金额:$14.69万
-
财政年份:2020
-
负责人:Donald Richieri Griffin
-
依托单位:
VEGF Gradients in Porous Hydrogels for Therapeutic Angiogenesis
-
批准号:8992266
-
项目类别:
-
资助金额:$6.0万
-
财政年份:2015
-
负责人:Donald Richieri Griffin
-
依托单位:
海外基金